Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy

Several European countries suspended or changed recommendations for the use of Vaxzevria (AstraZeneca) for suspected adverse effects due to atypical blood-clotting. This research aims to identify a reference point towards the number of thrombotic events expected in the Italian population over 50 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldi, Ileana, Azzolina, Danila, Francavilla, Andrea, Bartolotta, Patrizia, Lorenzoni, Giulia, Vanuzzo, Diego, Gregori, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620372/
https://www.ncbi.nlm.nih.gov/pubmed/34835237
http://dx.doi.org/10.3390/vaccines9111307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620372/
https://www.ncbi.nlm.nih.gov/pubmed/34835237
http://dx.doi.org/10.3390/vaccines9111307

Ejemplares similares